HomeFileCoronary disease

Coronary disease

View Category

Coronary disease

Bioresorbable scaffolds with drug-eluting stents: do they entail a higher thrombosis risk?

Courtesy of Dr. Leiva. Bioresorbable scaffolds with drug-eluting stents (bioresorbable vascular scaffolds, BVS) have been added to the...
solaci -
Learn More
Coronary disease

Proximal anterior descending artery angioplasty: what are its long-term outcomes?

Courtesy of Dr. Javier Castro. Certain coronary lesions have been historically discouraged for endovascular treatment. Among these can...
solaci -
Learn More
Coronary disease

Catheter-directed thrombolysis for pulmonary embolism: a safe technique

Courtesy of Dr. Brian Nazareth Donato. The conventional treatment for patients with pulmonary embolism (PE) has traditionally been...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

Infarction in Cariogenic Shock: Prioritizing the Use of Impella Could Improve Survival

This small study suggests the early use of Impella ventricular support device in patients undergoing AMI complicated...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

FFR-Guided ACS Revascularization Apparently Superior to Culprit Vessel Treatment

Using fractional flow reserve (FFR) to guide revascularization of all functionally significant lesions in the setting of...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

Higher Radiation Dose in Patients and Operators with Radial Approach (RAD-MATRIX Dosimeter)

Both physicians and patients are exposed to higher radiation doses during radial access PCI compared to femoral,...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

DECISION-CTO: Prevailing Questions on CTO Rechanneling

The first and only randomized trial on chronic total occlusion (CTO) revascularization versus optimal medical therapy in...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

ABSORB III: More Events with Absorb Than With Xience at Two Years

The two year outcomes of ABSORB III, presented at the scientific sessions of the American College of...
solaci -
Learn More